Heat hyperalgesia induced by endoneurial nerve growth factor and the expression of substance P in primary sensory neurons

International Journal of Neuroscience

Volumn 119, Issue 2, 2009, Pages 185-203

  Ruiz, Guido ^a,b   Banos, Josep E ^b,c  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Dorsal horn; Dorsal root ganglion; Formalin test; Heat hyperalgesia; Nerve growth factor; Substance P

Indexed keywords

FORMALDEHYDE; NERVE GROWTH FACTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PAIN ASSESSMENT; PROTEIN EXPRESSION; RAT; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

AFFERENT PATHWAYS; ANIMALS; GANGLIA, SPINAL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; NERVE GROWTH FACTOR; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; SUBSTANCE P;

EID: 58149252102     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450802333920     Document Type: Article

References (64)

1. Baranowski, A. P., Priestley, J. V., & McMahon, S. B. (1993). Substance P in cutaneous primary sensory neurons - a comparison of models of nerve injury that allow varying degrees of regeneration. Neuroscience, 55, 1025-1036.
2. Boucher, T. J., Kerr, B., Ramer, M., Thompson, S., & McMahon, S. B. (2000). Neurotrophic factor effects on pain-signaling systems. In Devor, M., Rowbotham, M. and Wiesenfeld-Hallin Z. (eds.). Proceedings of the 9th World Congress on pain. Seattle, WA: IASP Press, 175-189.
3. Bowles, W. R., Sabino, M., Harding-Rose, C., & Hargreaves, K. M. (2004). Nerve growth factor treatment enhances release of immunoreactive calcitonin gene-related peptide but not substance P from spinal dorsal horn slices in rats. Neuroscience Letters, 363, 239-242.
4. Cahill, C. M. & Coderre, T. J. (2002). Attenuation of hyperalgesia in a rat model of neuropathic pain after inthratecal pre- or post-treatment with a neurokinin-1 antagonist. Pain, 95, 277-285.
5. Calcutt, N. A., Stiller, C., Gustaffson, H., & Malmberg, A. B. (2000). Elevated substance P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Research, 856, 20-27.
6. Cameron, A. A., Cliffer, K. D., Dougherty, P. M., Garrison, C. J., Willis, W. D., & Carlton, S. M. (1997). Time course of degenerative and regenerative changes in the dorsal horn in a rat model of peripheral neuropathy. The Journal of Comparative Neurology, 379, 428-442.
7. Campbell, E. A., Gentry, C. T., Patel, S., Panesar, M. S., Walpole, C. S. J., & Urban, L. (1998). Selective neurokinin-1 receptor antagonist are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience, 87, 527-532.
8. Donnerer, J., Schuligoi, R., Stein, C., & Amann, R. (1993). Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor. Regulatory Peptides, 46, 150-154.
9. Dubuisson, D. & Dennis, S. G. (1977). The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 4, 161-164.
10. Duggan, A. W., Morton, C. R., Zhao, Z. Q., & Hendry, I. A. (1987). Noxious heating of the skin releases immunoreactive substance P in the substantia gelatinosa of the cat: A study with antibody microprobes. Brain Research, 403, 345-349.
11. Fitzgerald, M., Wall, P. D., Goedert, M., & Emson, P. C. (1985). Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve sections. Brain Research, 332, 131-141.
12. Gaddum, J. H. & Schild, H. (1935). Depressor substances in extracts of intestine. The Journal of Physiology (London), 83, 1-14.
13. Go, V. L. & Yaksh, T. L. (1987). Release of substance P from the cat spinal cord. The Journal of Physiology (London), 391, 141-167.
14. 1 receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain. The Journal of Pharmacology and Experimental Therapeuticals, 294, 444-450.
15. Hall, A. K., Ai, X., Hickman, G. E., MacPhedran, S. E., Nduaguba, C. O., & Robertson, C. P. (1997). The generation of neuronal heterogeneity in a rat sensory ganglion. The Journal of Neuroscience, 17, 2775-2784.
16. Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
17. Henry, J. L., Yashpal, K., Pitcher, G. M., Chabot, J. G., & Coderre, T. J. (1999). Evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the rat. The Journal of Neuroscience, 19, 6588-6598.
18. Herzberg, U., Eliav, E., Dorsey, J. M., Gracely, R. H., & Kopin, I. J. (1997). NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport, 8, 1613-1618.
19. 1 (substance P) antagonists-why are they not analgesic in humans? Trends in Pharmacological Sciences, 21, 244-246.
20. Honoré, P., Menning, P. M., Rogers, S. D., Nichols, M. L., Basbaum, A. I., Besson, J. M., & Mantyh, P. W. (1999). Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. The Journal of Neuroscience, 19, 7670-7678.
21. Hökfelt, T., Kellerth, J. O., Nilsson, G., & Pernow, B. (1975). Substance P: Localization in the central nervous system and in some primary sensory neurons. Science, 190, 889-890.
22. Inaishi, Y., Kashihara, Y., Sakaguchi, M., Nawa, H., & Kuno, M. (1992). Cooperative regulation of calcitonin gene-related peptide levels in rat sensory neurons via their central and peripheral processes. The Journal of Neuroscience, 12, 518-524.
23. Jang, J. H., Nam, T. S., Paik, K. S., & Leem, J. W. (2004). Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neurosci Letters, 360, 129-132.
24. Kajander, K. C., Pollock, C. H., & Berg, H. (1992). Evaluation of hindpaw position in rats during chronic constriction injury (CCI) produced with different suture materials. Experimental Brain Research, 91, 73-78.
25. Kanai, Y., Nakazato, E., Fujiuchi, A., Hara, T., & Imai, A. (2005). Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neurophamacology, 49, 977-984.
26. Kawasaki, Y., Kohno, T., Zhuang, Z.-Y., Brenner, G. J., Wang, H., Van Der Meer, C., Befort, K., Woolf, C. J., & Ji, R.-R. (2004). Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. The Journal of Neuroscience, 24, 8310-8321.
27. Khasabov, S. G., Ghilardi, J. R., Mantyh, P. W., & Simone, D. A. (2005). Spinal neurons that express NK-1 receptors modulate descending controls that project through the dorsolateral funiculus. Journal of Neurophysiology, 93, 998-1006.
28. Khasabov, S. G., Rogers, S. D., Ghilardi, J. R., Peters, C. M., Mantyh, P. W., & Simone, D. A. (2002). Spinal neurons that possess the substance P receptor are required for the development of central sensitization. The Journal of Neuroscience, 22, 9086-9098.
29. Kingery, W. S., Davies, M. F., & Clark, J. D. (2003). A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain, 104, 75-84.
30. Li, L., Xian, C. J., Zhong, J.-H., & Zhou, X.-F. (2003). Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: A mechanism in neuropathic pain. Molecular and Cellular Neuroscience, 23, 232-250.
31. Lindsay, R. M. & Harmar, A. J. (1989). Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature, 337, 362-364.
32. Ma, W. & Bisby, M. A. (1998). Increase of preprotachykinin mRNA and substance P immunoreactivity in spared dorsal root ganglion neurons following partial sciatic nerve injury. The European Journal of Neuroscience, 10, 2388-2399.
33. Ma, W. & Eisenach, J. C. (2003). Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, clacitonin gene-related peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation. Neuroscience, 121, 681-690.
34. Malcangio, M., Garrett, N. E., & Tomlinson, D. R. (1997). Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. The European Journal of Neuroscience, 9, 1101-1104.
35. Mansikka, H., Sheth, R. N., DeVries, C., Lee, H., Winchurch, R., & Raja, S. N. (2000). Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Experimental Neurology, 162, 343-349.
36. Mason, L., Moore, R. A., Derry, S., Edwards, J. E., & McQuay, H. J. (2004). Systematic review of topical capsaicin for the treatment of chronic pain. BMJ, 328, 991
37. McCarthy, P. W. & Lawson, S. N. (1989). Cell type and conduction velocity of rat primary sensory neurons with substance P-like immunoreactivity. Neuroscience, 28, 745-753.
38. Munglani, R., Bond, A., Smith, G. D., Harrison, S. M., Elliot, P. J., Birch, P. J., & Hunt, S. P. (1995). Changes in neuronal markers in a mononeuropathic rat model: Relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesia. Pain, 63, 21-31.
39. Neumann, S., Doubell, T. P., Leslie, T., & Woolf, C. J. (1996). Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature, 384, 360-364.
40. Nichols, M. L., Allen, B. J., Rogers, S. D., Ghilardi, J., Honoré, P., Luger, N. M., Finke, M. P., Li, J., Lappi, D. A., Simone, D. A., & Mantyh, P. W. (1999). Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science, 286, 1558-1561.
41. Noguchi, K., Kawai, Y., Fukuoka, T., Senba, E., & Miki, K. (1995). Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons. The Journal of Neuroscience, 15, 7633-7643.
42. Nolano, M., Simone, D. A., Wendelschafer-Crabb, G., Johnson, T., Hazen, E., & Kennedy, W. R. (1999). Topical capsaicin in humans: Parallel loss of epidermal nerve fibers and pain sensation. Pain, 81, 135-145.
43. Nothias, F., Tessler, A., & Murray, M. (1993). Restoration of substance P and calcitonin gene-related peptide in dorsal root ganglia and dorsal horn after neonatal sciatic nerve lesion. The Journal of Comparative Neurology, 334, 370-384.
44. Ohkubo, T., Shibata, M., Takahashi, H., & Inoki, R. (1990). Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord. The Journal of Pharmacology and Experimental Therapeutics, 252, 1261-1268.
45. Pezet, S., Malcangio, M., & McMahon, S. B. (2002). BDNF: A neuromodulator in nociceptive pathways? Brain Research, 40, 240-249.
46. Pezet, S., Onténiente, B., Jullien, J., Junier, M. P., Grannec, G., Rudkin, B. B., and Calvino, B. (2001). Differential regulation of NGF receptors in primary sensory neurons by adjuvant-induced arthritis in the rat. Pain, 90, 113-125.
47. Pitcher, G. M. & Henry, J. L. (2002). Second phase of formalin-induced excitation of spinal dorsal horn neurons in spinalized rats is reversed by sciatic nerve block. The European Journal of Neuroscience, 15, 1509-1515.
48. Radhakrishnan, V. & Henry, J. L. (1991). Novel substance P antagonist, CP-96, 345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neuroscience Letters, 132, 39-43.
49. Ramer, M. S. & Bisby, M. A. (1999). Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: Distinct mechanisms revealed by anti-NGF treatment. The European Journal of Neuroscience, 11, 837-846.
50. Richardson, P. M. & Riopelle, R. J. (1984). Uptake of nerve growth factor along peripheral and spinal axons of primary sensory neurons. The Journal of Neuroscience, 4, 1683-1689.
51. Ruiz, G. & Baños, J.-E. (2005). The effect of endoneurial nerve growth factor on calcitonin gene-related peptide expression in primary sensory neurons. Brain Research, 1042, 44-52.
52. Ruiz, G., Ceballos, D., & Baños, J.-E. (2004). Behavioral and histological effects of endoneurial administration of nerve growth factor: Possible implications in neuropathic pain. Brain Research, 1011, 1-6.
53. Schaible, H. G., Jarrott, B., Hope, P. J., & Duggan, A. W. (1990). Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint in the cat: A study with antibody microprobes. Brain Research, 529, 214-223.
54. Stoeckel, K., Schwab, M. E., & Thoenen, H. (1975). Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: A biochemical and morphological study. Brain Research, 89, 1-14.
55. Suzuki, R., Morcuende, S., Webber, M., Hunt, S. P., & Dickenson, A. H. (2002). Superficial NK-1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neuroscience, 5, 1319-1326.
56. Todd, A., Puskár, Z., Spike, R. C., Hughes, C., Watt, C., & Forrest, L. (2002). Projection neurons in lamina I of rat spinal cord with the neurokinin 1 receptor are selectively innervated by substance P-containing afferents and respond to noxious stimulation. Journal of Neuroscience, 22, 4103-4113.
57. Traub, R. J. (1996). The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain, 67, 151-161.
58. Verge, V. M. K., Richardson, P. M., Wiesenfeld-Hallin, Z., & Hökfelt, T. (1995). Differential influence of nerve growth factor on neuropeptide expression in vivo: A novel role in peptide suppression in adult sensory neurons. Journal of Neuroscience, 15, 2081-2096.
59. Von Euler, U. S. & Gaddum, J. H. (1931). An unidentified depressor substance in certain tissue extracts. Journal of Physiology, 72, 74-87.
60. Watson, G. S., Sufka, K. J., & Coderre, T. J. (1997). Optimal scoring strategies and weights for the formalin test in rats. Pain, 70, 53-58.
61. Wiberg, M., Ljungberg, C., O'Byrne, A., Brown, R., Whitworth, I., Liss, A., & Terenghi, G. (1999). Primary sensory neuron survival following targeted administration of nerve growth factor to an injured nerve. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 33, 387-392.
62. Yamamoto, T. & Yaksh, T. L. (1992). Effects of intrathecal capsaicin and an NK-1 antagonist, CP, 96-345, on the thermal hyperalgesia observed following unilateral constriction of the sciatic nerve in the rat. Pain, 51, 329-334.
63. Zimmer, A., Zimmer, A. M., Baffi, J., Usdin, T., Reynolds, K., König, M., Palkovits, M., & Mezey, E. (1998). Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proceedings of the National Academy of Science, 95, 2630-2635.
64. Zimmermann, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110.